Bernard Castan

670 total citations
23 papers, 181 citations indexed

About

Bernard Castan is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, Bernard Castan has authored 23 papers receiving a total of 181 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Infectious Diseases and 7 papers in Applied Microbiology and Biotechnology. Recurrent topics in Bernard Castan's work include Antibiotic Use and Resistance (7 papers), Pneumonia and Respiratory Infections (5 papers) and Pelvic floor disorders treatments (4 papers). Bernard Castan is often cited by papers focused on Antibiotic Use and Resistance (7 papers), Pneumonia and Respiratory Infections (5 papers) and Pelvic floor disorders treatments (4 papers). Bernard Castan collaborates with scholars based in France, Canada and Belgium. Bernard Castan's co-authors include R. Gauzit, É. Bonnet, P. Lesprit, Laurence Maulin, Mercedes Iñarrairaegui, S. Diamantis, C. Strady, G. M. Pastor, José Manuel Zozaya and Emmanuelle Varon and has published in prestigious journals such as Scientific Reports, Journal of Antimicrobial Chemotherapy and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Bernard Castan

17 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Castan France 8 67 53 37 34 28 23 181
Tewodros Tesfa Ethiopia 12 121 1.8× 52 1.0× 73 2.0× 28 0.8× 24 0.9× 32 329
Cheri Grigg United States 7 142 2.1× 35 0.7× 76 2.1× 19 0.6× 24 0.9× 10 248
Sittana S. Elshafie Qatar 11 136 2.0× 49 0.9× 69 1.9× 46 1.4× 43 1.5× 25 321
Claire M. Italiano Australia 8 75 1.1× 27 0.5× 54 1.5× 23 0.7× 7 0.3× 17 223
Ayşegül Ulu-Kılıç Türkiye 10 73 1.1× 53 1.0× 88 2.4× 23 0.7× 25 0.9× 26 258
OC Abraham India 11 88 1.3× 89 1.7× 111 3.0× 44 1.3× 13 0.5× 26 338
Paola Lichtenberger United States 9 151 2.3× 27 0.5× 16 0.4× 27 0.8× 20 0.7× 18 251
Yohann Dubois France 5 155 2.3× 30 0.6× 41 1.1× 39 1.1× 34 1.2× 7 339
Dàmaris Berbel Spain 11 111 1.7× 22 0.4× 83 2.2× 65 1.9× 40 1.4× 27 278
Soichi Shiiki Japan 8 71 1.1× 16 0.3× 38 1.0× 42 1.2× 49 1.8× 17 168

Countries citing papers authored by Bernard Castan

Since Specialization
Citations

This map shows the geographic impact of Bernard Castan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Castan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Castan more than expected).

Fields of papers citing papers by Bernard Castan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Castan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Castan. The network helps show where Bernard Castan may publish in the future.

Co-authorship network of co-authors of Bernard Castan

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Castan. A scholar is included among the top collaborators of Bernard Castan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Castan. Bernard Castan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Timsit, Jean‐François, Joy Mootien, Bernard Castan, et al.. (2024). Ceftolozane/Tazobactam for the Treatment of Complicated Infections in Hospital Settings—A French Real-world Study. Open Forum Infectious Diseases. 11(2). ofae037–ofae037. 3 indexed citations
2.
Castan, Bernard, Anne Vuillemin, Julie Chastang, et al.. (2024). The French medical community united against cuts to State Medical Aid. Health Policy. 143. 105037–105037.
4.
Bonnet, É., Laurence Maulin, Éric Senneville, et al.. (2023). Clinical practice recommendations for infectious disease management of diabetic foot infection (DFI) – 2023 SPILF. Infectious Diseases Now. 54(1). 104832–104832. 8 indexed citations
5.
Stahl, J.‐P., Bernard Castan, É. Bonnet, et al.. (2022). Utilization of macrolides. State of the art 2022 Spilf and GPIP. Infectious Diseases Now. 52(5). 252–266.
6.
7.
Gauzit, R., Bernard Castan, É. Bonnet, et al.. (2021). Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendations. Infectious Diseases Now. 51(2). 114–139. 20 indexed citations
8.
Castan, Bernard, L. Lévy-Bachelot, Joy Mootien, et al.. (2021). Real-world evaluation of ceftolozane/tazobactam therapy and clinical outcomes in France. Infectious Diseases Now. 51(6). 532–539. 7 indexed citations
10.
Brun, J.-L., Bernard Castan, Bertille de Barbeyrac, et al.. (2020). Pelvic inflammatory diseases: Updated French guidelines. Journal of Gynecology Obstetrics and Human Reproduction. 49(5). 101714–101714. 14 indexed citations
11.
Stahl, J.‐P., J.P. Bru, Jean-François Gehanno, et al.. (2020). Guidelines for the management of accidental exposure to Brucella in a country with no case of brucellosis in ruminant animals. Médecine et Maladies Infectieuses. 50(6). 480–485. 2 indexed citations
12.
Lévy-Bachelot, L., Bernard Castan, Raymond Ruimy, et al.. (2020). PIN91 Ceftolozane-Tazobactam for the Treatment of Pneumonia Due to MULTI-Drug Resistant Ps eudomonas Aeruginosa - Results from a French Real-World Study. Value in Health. 23. S560–S560.
13.
Castan, Bernard. (2019). Prévention des infections génitales hautes postopératoires ou associées aux soins. RPC infections génitales hautes CNGOF et SPILF. Gynécologie Obstétrique Fertilité & Sénologie . 47(5). 451–457. 4 indexed citations
14.
Béraud, Guillaume, Bernard Castan, R. Gauzit, et al.. (2019). Impact of the French Infectious Diseases Society's (SPILF) proposals for shorter antibiotic therapies. Médecine et Maladies Infectieuses. 49(6). 456–462. 3 indexed citations
15.
Brun, J.-L., Bernard Castan, Bertille de Barbeyrac, et al.. (2019). Les infections génitales hautes. Mise à jour des recommandations pour la pratique clinique – texte court. Gynécologie Obstétrique Fertilité & Sénologie . 47(5). 398–403. 4 indexed citations
16.
Wintenberger, C., Benoît Guéry, É. Bonnet, et al.. (2017). Proposal for shorter antibiotic therapies. Médecine et Maladies Infectieuses. 47(2). 92–141. 52 indexed citations
17.
Lemaire, X., É. Bonnet, Bernard Castan, et al.. (2016). Management of non-necrotizing cellulitis in France. Médecine et Maladies Infectieuses. 46(7). 355–359. 4 indexed citations
18.
Cálvez, Vincent, Laurent Hocqueloux, Jean‐Luc Meynard, et al.. (2016). Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why?. Journal of Antimicrobial Chemotherapy. 72(1). 19–28. 4 indexed citations
19.
Castan, Bernard, et al.. (2014). Mycobacterium marinum infection following contact with reptiles: vivarium granuloma. International Journal of Infectious Diseases. 21. 17–18. 15 indexed citations
20.
Castan, Bernard, Fernando Borda, Mercedes Iñarrairaegui, et al.. (2002). Digestive anisakiasis: clinical manifestations and diagnosis according to localization.. PubMed. 94(8). 463–72. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026